NCT00698035 · OUTCOME

Total Testosterone Levels

Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients · Source last updated 2014-06-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEAN
Unit: ng/dl
Interval / dispersion: Standard Deviation
Time frame: 12 weeks

What was measured

By serum ultrasensitive total testosterone test (Quest Diagnostics)

Analysis population: Per protocol, participants assigned to the Testosterone arm who completed 12 weeks of assigned treatment and had testosterone measurement at baseline, 4 weeks and 12 weeks.

Groups in this outcome

Testosterone Cream

Testosterone Cream 1% micronized in velvachol - 0.5 gm of cream vaginally each night for two weeks, then 3 times a week for total of 12 weeks of treatment

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Testosterone Cream	27

Reported measurements

Testosterone at baseline

Values in ng/dl · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Testosterone Cream	33	19	Not reported	Not reported	Not reported

Testosterone at 4 weeks

Values in ng/dl · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Testosterone Cream	186	276	Not reported	Not reported	Not reported

Testosterone at 12 weeks

Values in ng/dl · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Testosterone Cream	171	251	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
spread
19
value
33
title
Testosterone at baseline
categories
measurements
group Id
OG000
spread
276
value
186
title
Testosterone at 4 weeks
categories
measurements
group Id
OG000
spread
251
value
171
title
Testosterone at 12 weeks

denoms

counts
group Id
OG000
value
27
units
Participants

description

By serum ultrasensitive total testosterone test (Quest Diagnostics)

dispersion Type

Standard Deviation

groups

description
Testosterone Cream 1% micronized in velvachol - 0.5 gm of cream vaginally each night for two weeks, then 3 times a week for total of 12 weeks of treatment
id
OG000
title
Testosterone Cream

param Type

MEAN

population Description

Per protocol, participants assigned to the Testosterone arm who completed 12 weeks of assigned treatment and had testosterone measurement at baseline, 4 weeks and 12 weeks.

reporting Status

POSTED

time Frame

12 weeks

title

Total Testosterone Levels

type

SECONDARY

unit Of Measure

ng/dl

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice